Preclinical Study on Bushen Gubiao Granules in Treating Children with Repeated Respiratory Infections

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000037534

Enrollment

Unknown

Registered

2020-08-28

Start date

2021-01-01

Completion date

Unknown

Last updated

2020-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Repeated respiratory infections in children

Interventions

Experimental group:Bushen Gubiao Granules

Control group:Yupingfeng loose particles

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for repeated respiratory infections; 2. Meet the standard of TCM syndrome differentiation; 3. No manifestations of acute respiratory infection; 4. Did not receive treatment outside the research program; 5. Aged 2 to 14 years old; 6. Parents with informed consent and willing to cooperate to complete the treatment.

Exclusion criteria

Exclusion criteria: (1) People with primary immunodeficiency; (2) Congenital respiratory malformations; (3) Combined with primary diseases of the heart, liver, kidney and hematopoietic system.

Design outcomes

Primary

Measure	Time frame
Curative effect;	—

Countries

China

Contacts

Public ContactWu Jie

Shanghai Traditional Chinese Medicine Hospital

shwj8055@sina.com+86 15221094112

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026